Device Makers Push Chronic Disease Platform For 2008 Election
This article was originally published in The Gray Sheet
Executive Summary
AdvaMed joined more than 50 health and labor organizations Sept. 25 in announcing a platform to increase the prominence of chronic disease treatment and prevention issues in the U.S. presidential race
You may also be interested in...
Device Industry Looks To SCHIP Bill For Medicare Reforms
A bill reauthorizing a health coverage program for uninsured children has become the vehicle of choice this year for device industry representatives seeking Medicare reforms
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.